Zhejiang Xianju Pharmaceutical Co.,Ltd.
SZSE:002332.SZ
10.99 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,086.553 | 4,379.826 | 4,337.151 | 4,018.873 | 3,708.546 | 3,621.755 | 2,852.555 | 2,503.73 | 2,480.246 | 2,470.533 | 2,315.041 | 1,992.192 | 1,689.21 | 1,500.981 | 1,276.721 | 1,133.517 | 966.789 | 765.331 |
| Cost of Revenue
| 1,991.409 | 1,832.759 | 1,811.714 | 1,782.897 | 1,463.332 | 1,481.812 | 1,245.879 | 1,228.618 | 1,395.789 | 1,515.271 | 1,517.51 | 1,201.86 | 1,009.791 | 926.483 | 742.833 | 696.533 | 594.764 | 492.501 |
| Gross Profit
| 2,095.144 | 2,547.066 | 2,525.437 | 2,235.975 | 2,245.213 | 2,139.942 | 1,606.676 | 1,275.113 | 1,084.457 | 955.262 | 797.531 | 790.331 | 679.419 | 574.498 | 533.888 | 436.983 | 372.025 | 272.83 |
| Gross Profit Ratio
| 0.513 | 0.582 | 0.582 | 0.556 | 0.605 | 0.591 | 0.563 | 0.509 | 0.437 | 0.387 | 0.344 | 0.397 | 0.402 | 0.383 | 0.418 | 0.386 | 0.385 | 0.356 |
| Reseach & Development Expenses
| 253.495 | 266.768 | 243.374 | 208.386 | 204.522 | 142.852 | 88.145 | 87.136 | 86.496 | 88.405 | 79.666 | 60.028 | 49.187 | 48.252 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 122.084 | 95.284 | 104.3 | 81.786 | 98.989 | 96.568 | 76.838 | 74.906 | 66.278 | 65.178 | 55.821 | 51.481 | 49.047 | 36.649 | 141.282 | 111.641 | 101.782 | 70.361 |
| Selling & Marketing Expenses
| 989.983 | 1,262.804 | 1,279.79 | 1,095.508 | 1,127.255 | 1,194.91 | 938.968 | 775.757 | 619.579 | 550.98 | 435.525 | 391.875 | 325.146 | 259.11 | 230.215 | 186.183 | 154.67 | 114.294 |
| SG&A
| 1,225.388 | 1,358.088 | 1,384.089 | 1,177.294 | 1,226.244 | 1,291.477 | 1,015.806 | 850.662 | 685.856 | 616.158 | 491.346 | 443.356 | 374.193 | 295.759 | 371.497 | 297.825 | 256.453 | 184.655 |
| Other Expenses
| -20.769 | 169.863 | 178.295 | 165.007 | 182.791 | -0.862 | -5.986 | 7.037 | 12.017 | 4.712 | 2.213 | -0.827 | 5.386 | 0.024 | 4.004 | 3.64 | 0.188 | 0.516 |
| Operating Expenses
| 1,499.652 | 1,794.719 | 1,805.758 | 1,550.686 | 1,613.557 | 1,612.037 | 1,227.11 | 1,070.043 | 903.237 | 817.074 | 671.761 | 590.767 | 497.308 | 408.723 | 379.831 | 304.584 | 262.606 | 188.648 |
| Operating Income
| 595.492 | 878.597 | 754.673 | 597.238 | 543.395 | 431.246 | 297.636 | 178.059 | 116.243 | 69.108 | 70.202 | 160.253 | 163.563 | 148.506 | 113.31 | 80.208 | 94.931 | 71.082 |
| Operating Income Ratio
| 0.146 | 0.201 | 0.174 | 0.149 | 0.147 | 0.119 | 0.104 | 0.071 | 0.047 | 0.028 | 0.03 | 0.08 | 0.097 | 0.099 | 0.089 | 0.071 | 0.098 | 0.093 |
| Total Other Income Expenses Net
| 54.141 | -6.705 | -28.788 | 24.011 | -16.098 | -97.522 | -87.916 | -22.04 | -53.319 | -65.011 | -55.681 | -45.614 | -14.832 | -18.084 | -38.054 | -49.285 | -15.705 | -12.94 |
| Income Before Tax
| 649.633 | 871.892 | 725.886 | 621.248 | 527.297 | 430.383 | 291.65 | 183.029 | 127.901 | 73.177 | 70.089 | 153.949 | 167.278 | 147.691 | 116.003 | 83.115 | 93.714 | 71.241 |
| Income Before Tax Ratio
| 0.159 | 0.199 | 0.167 | 0.155 | 0.142 | 0.119 | 0.102 | 0.073 | 0.052 | 0.03 | 0.03 | 0.077 | 0.099 | 0.098 | 0.091 | 0.073 | 0.097 | 0.093 |
| Income Tax Expense
| 79.562 | 124.506 | 108.007 | 92.25 | 84.819 | 85.013 | 61.551 | 36.617 | 23.299 | 24.359 | 19.479 | 29.723 | 35.245 | 33.08 | 31.372 | 20.991 | 32.359 | 20.885 |
| Net Income
| 563.083 | 749.411 | 619.326 | 504.509 | 410.369 | 301.363 | 206.63 | 146.187 | 106.551 | 56.696 | 60.591 | 120.557 | 132.87 | 120.166 | 88.842 | 65.038 | 64.636 | 49.53 |
| Net Income Ratio
| 0.138 | 0.171 | 0.143 | 0.126 | 0.111 | 0.083 | 0.072 | 0.058 | 0.043 | 0.023 | 0.026 | 0.061 | 0.079 | 0.08 | 0.07 | 0.057 | 0.067 | 0.065 |
| EPS
| 0.57 | 0.76 | 0.63 | 0.51 | 0.45 | 0.33 | 0.23 | 0.16 | 0.13 | 0.073 | 0.08 | 0.16 | 0.17 | 0.16 | 0.16 | 0.11 | 0.11 | 0.084 |
| EPS Diluted
| 0.57 | 0.76 | 0.63 | 0.51 | 0.45 | 0.33 | 0.23 | 0.16 | 0.13 | 0.073 | 0.08 | 0.16 | 0.17 | 0.16 | 0.16 | 0.11 | 0.11 | 0.084 |
| EBITDA
| 815.58 | 1,020.995 | 932.675 | 856.183 | 760.875 | 656.831 | 460.314 | 329.483 | 306.498 | 235.519 | 198.474 | 255.911 | 244.787 | 215.176 | 201.471 | 177.792 | 137.761 | 124.46 |
| EBITDA Ratio
| 0.2 | 0.233 | 0.215 | 0.213 | 0.205 | 0.181 | 0.161 | 0.132 | 0.124 | 0.095 | 0.086 | 0.128 | 0.145 | 0.143 | 0.158 | 0.157 | 0.142 | 0.163 |